Mitochondrial Fission Mediates Endothelial Inflammation
Steven J. Forrester(Emory University), Satoru Eguchi(University of South Florida), Anthony J. Poltronetti(Temple University), Hiromi Sesaki(Johns Hopkins University), Yayoi Kimura(Yokohama City University Medical Center), Kathleen M. Escoto(Temple University), Tomoko Akiyama(Yokohama City University Medical Center), Kyle Preston(Temple University), Michael Boyer(Chris O’Brien Lifehouse), Hannah Cooper(Temple University), Rosario Scalia(Thomas Jefferson University), Katherine J. Elliott(Cornell University), Victor Rizzo(University of Iowa), Ryohei Kuroda(Temple University), Masashi Miyao(Kyoto University)
Cited by 97
Related Papers
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
|Journal of Clinical Oncology|2003|3.1k
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
|Circulation Research|2018|2k